Postpartum haemorrhage resources

Stay up to date on the latest advances in and best practice recommendations for preventing postpartum haemorrhage.

Recommendations and guidelines

• WHO recommendations for prevention and treatment of PPH
  World Health Organization recommendations for the prevention and treatment of postpartum haemorrhage. 2012
  
  
• WHO model list of essential medicines
  World Health Organization Model List of Essential Medicines 2011, Section 22.1
  
  
• WHO statement on use of misoprostol for PPH
  WHO Statement regarding the use of misoprostol for postpartum haemorrhage prevention and treatment. 2010

Studies

• Misoprostal to prevent PPH in home birth settings in low resource countries
  Should oral misoprostol be used to prevent postpartum haemorrhage in home-birth settings in low-resource countries? A systematic review of the evidence. British Journal of Obstetrics & Gynaecology Volume 120, Issue 3, pages 277–287, February 2013
  
  
• Treatment of PPH with sublingual misoprostol versus oxytocin
  Blum, J, Winikoff B, et al. Treatment of postpartum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial. Lancet 2010; 375(9710): 210–16.

Useful links for all indications

• WHO
• FIGO
• Reproductive Health Access Project
• National Abortion Federation